These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31830258)

  • 41. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
    BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of cholecalciferol treatment on biomarkers of inflammation and myocardial structure in hemodialysis patients without hyperparathyroidism.
    Bucharles S; Barberato SH; Stinghen AEM; Gruber B; Piekala L; Dambiski AC; Custodio MR; Pecoits-Filho R
    J Ren Nutr; 2012 Mar; 22(2):284-291. PubMed ID: 21908203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholecalciferol Supplementation Did Not Change Interleukin-7 and B cell-Activating Factor Levels and CD95 Expression in B lymphocytes in Patients on Dialysis: A Randomized Pilot-Controlled Trial.
    de Carvalho JTG; Schneider M; Cuppari L; Grabulosa CC; Cendoroglo M; Dalboni MA
    J Ren Nutr; 2019 Sep; 29(5):454-461. PubMed ID: 30686751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.
    Alvarez JA; Law J; Coakley KE; Zughaier SM; Hao L; Shahid Salles K; Wasse H; Gutiérrez OM; Ziegler TR; Tangpricha V
    Am J Clin Nutr; 2012 Sep; 96(3):672-9. PubMed ID: 22854402
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
    Xie X; Liu Y; Perkovic V; Li X; Ninomiya T; Hou W; Zhao N; Liu L; Lv J; Zhang H; Wang H
    Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Vitamin D Supplementation on Serum Hepcidin Levels in Non-Diabetic Chronic Kidney Disease Patients.
    Kamboj K; Yadav AK; Kumar V; Jha V
    Indian J Nephrol; 2023; 33(6):444-448. PubMed ID: 38174303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of high-dose vitamin D supplementation on hepcidin-25 and erythropoiesis in patients with chronic kidney disease.
    Pistis KD; Westerberg PA; Qureshi AR; Beshara S; Sterner G; Bárány P; Linde T
    BMC Nephrol; 2023 Jan; 24(1):20. PubMed ID: 36698076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Randomized Double-Blind Placebo-Controlled Trial Evaluating the Efficacy of Oral Cholecalciferol in Improving Renal and Vascular Functions in Vitamin D-Deficient Patients With Type 2 Diabetes Mellitus.
    Das S; Selvarajan S; Kamalanathan S; Parameswaran S; Zachariah B
    J Diet Suppl; 2023; 20(1):44-54. PubMed ID: 34387520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effects of oral vitamin D
    Tahar A; Zerdoumi F; Saidani M; Griene L; Koceir EA
    Ann Biol Clin (Paris); 2018 Jun; 76(3):313-325. PubMed ID: 29661746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aldosterone antagonists for preventing the progression of chronic kidney disease.
    Bolignano D; Palmer SC; Navaneethan SD; Strippoli GF
    Cochrane Database Syst Rev; 2014 Apr; (4):CD007004. PubMed ID: 24782282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cholecalciferol, Calcitriol, and Vascular Function in CKD: A Randomized, Double-Blind Trial.
    Kendrick J; Andrews E; You Z; Moreau K; Nowak KL; Farmer-Bailey H; Seals DR; Chonchol M
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1438-1446. PubMed ID: 28784657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Native vitamin D in pre-dialysis chronic kidney disease.
    Cardoso MP; Pereira LAL
    Nefrologia (Engl Ed); 2019; 39(1):18-28. PubMed ID: 30274806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial.
    Gaughran F; Stringer D; Berk M; Smith S; Taylor D; Whiskey E; Landau S; Murray R; McGuire P; Gardner-Sood P; Wojewodka G; Ciufolini S; Jordan H; Clarke J; Allen L; Krivoy A; Stubbs B; Lowe P; Arbuthnott M; Rathod S; Boardman A; Firdosi M; McGrath JJ
    Trials; 2020 Jan; 21(1):14. PubMed ID: 31907006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of 25-hydroxyvitamin D deficiency in promoting insulin resistance and inflammation in patients with chronic kidney disease: a randomised controlled trial.
    Petchey WG; Hickman IJ; Duncan E; Prins JB; Hawley CM; Johnson DW; Barraclough K; Isbel NM
    BMC Nephrol; 2009 Dec; 10():41. PubMed ID: 20003316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.
    Bhandari S; Ives N; Brettell EA; Valente M; Cockwell P; Topham PS; Cleland JG; Khwaja A; El Nahas M
    Nephrol Dial Transplant; 2016 Feb; 31(2):255-61. PubMed ID: 26429974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The VITAH trial VITamin D supplementation and cardiac Autonomic tone in Hemodialysis: a blinded, randomized controlled trial.
    Mann MC; Exner DV; Hemmelgarn BR; Hanley DA; Turin TC; MacRae JM; Ahmed SB
    BMC Nephrol; 2014 Aug; 15():129. PubMed ID: 25098377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treating endothelial dysfunction with vitamin D in chronic kidney disease: a meta-analysis.
    Lundwall K; Jacobson SH; Jörneskog G; Spaak J
    BMC Nephrol; 2018 Sep; 19(1):247. PubMed ID: 30253741
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
    Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial.
    Luger M; Kruschitz R; Marculescu R; Haslacher H; Hoppichler F; Kallay E; Kienbacher C; Klammer C; Kral M; Langer F; Luger E; Prager G; Trauner M; Traussnigg S; Würger T; Schindler K; Ludvik B
    Trials; 2015 Aug; 16():328. PubMed ID: 26242295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of weekly vitamin D
    Lozano-Plata LI; Vega-Morales D; Esquivel-Valerio JA; Garza-Elizondo MA; Galarza-Delgado DA; Silva-Luna K; Serna-Peña G; Sifuentes-Ramírez J; Garza-Guerra AJ; Díaz-Niño de Rivera R
    Clin Rheumatol; 2021 Aug; 40(8):3257-3264. PubMed ID: 33570701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.